Senescence in Human Mesenchymal Stem Cells: Functional Changes and Implications in Stem Cell-Based Therapy.
Turinetto V, Vitale E, Giachino C. · 2016
Read Senescence in Human Mesenchymal Stem Cells: Functional Changes and Implications in Stem Cell-Based Therapy. by Turinetto V, Vitale E, Giachino C. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4964536.txt.
Description
Valentina Turinetto, Emanuela Vitale, and Claudia Giachino review senescence in human mesenchymal stem cells and what it means for cell therapy. Their review appeared in the International Journal of Molecular Sciences in 2016. These stem cells are prized for regenerative medicine and for aging related disease. Therapy needs huge cell numbers, which forces long growth in culture. Over that time many cells senesce, entering a worn, non-dividing state with changed behavior.
Senescent cells lose much of their power to become bone, fat, or cartilage. Their ability to migrate and home to injury sites also fades. Their secreted mix can fan inflammation body wide, blunt immune calming, and even help cancer cells grow or spread. The authors argue therapy makers must watch senescence as a quality risk. Fresh, well checked cell batches, they say, are a condition for the field's promise to hold.
Catalog record
| CREATOR | Turinetto V, Vitale E, Giachino C. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 74 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |